June 2, 2023
MUNICH, Germany — Rodenstock Eyewear has joined the myopia control spectacle lens arena with the development of MyCon (the name comes from Myopia Control), lenses that are specially designed to correct myopia and ensure sharp vision while controlling myopia progression in children.
Rodenstock’s MyCon lenses correct myopia while controlling eye elongation, ultimately slowing myopia progression. With MyCon lenses, light in the periphery is refracted to hit in front of the retina, slowing eye elongation, which is a crucial aspect of maintaining children’s vision. The progression control areas in MyCon lenses are placed to the sides of the lens to ensure that light in the periphery does not hit behind the retina. Here, they slow myopia progression or eye elongation, while leaving the main vision zones of the lens undisturbed, creating sharp vision. The focus area in the lens ensures that the child can see sharply wherever they focus their eyes.
An independent clinical study examining myopia progression in Caucasian children aged 7 to 14 years over a period of five years has shown that myopia control lenses built on the principles of Rodenstock MyCon are effective in reducing the progression of myopia by up to 40%. Furthermore, axial elongation was reduced by up to 56% after two years and 35% after four to five years.1
Rodenstock MyCon lenses are available in index 1.5, 1.6, 1.67, and 1.74, which make the lenses both thinner and sleeker than many other myopia lenses on the market.
[Note: Rodenstock MyCon lenses are not available in the United States. MyCon lenses are currently available in Australia, Germany, Austria, Switzerland, Belgium, Brazil, Chile, Czech Republic, Denmark, France, Italy, Netherlands, Norway, Poland, Slovakia, Slovenia, Sveden, Thailand, and the U.K.]
Tarutta, E. P., Proskurina, O. V., Tarasova, N. A., Milash, S. V., & Markosyan, G. A. (2019). Long-term results of perifocal defocus spectacle lens correction in children with progressive myopia. Vestnik Oftal’mologii, 135(5), 46. https://doi.org/10.17116/oftalma201913505146